| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 674960 | 62639 | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 250 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62639/62639_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62639/62639_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674994 | 62636 | CEFTRIAXONA NORMON 500 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG | CEFTRIAXONA NORMON 500 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG, 1 vial + 1 ampolla de disolvente | 500 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62636/62636_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62636/62636_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 672136 | 08463001 | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE, 1 vial de 0,6 ml | 12 mg | 45 | 1 | 34 | 1 vial de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08463001/08463001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08463001/08463001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30213 | ZENTIVA SPAIN S.L. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2011-03-28 | 1 | 2012-03-22 | 662079 | View Edit Delete | |||||||||||
| 673037 | 06337011 | M-M-RVAXPRO POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA | M-M-RVAXPRO POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 vial + 1 jeringa precargada de disolvente | N/A (vacuna) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06337011/06337011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06337011/06337011_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2006-06-06 | 1 | 1 | 1 | 2006-06-06 | 2011-06-20 | 1 | 2011-10-05 | 654487, 663210 | View Edit Delete | |||||||||||
| 672096 | 51174 | COLIRCUSI GENTADEXA 5 MG/ML+ 1 MG/ML+ 0,5 MG/ML COLIRIO/GOTAS ÓTICAS EN SOLUCIÓN | COLIRCUSI GENTADEXA 5 MG/ML+ 1 MG/ML+ 0,5 MG/ML COLIRIO/GOTAS ÓTICAS EN SOLUCIÓN 1 frasco de 10 ml | 3 mg/ml + 1 mg/ml + 0,5 mg/ml | 56 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/51174/51174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/51174/51174_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11601 | NTC OPHTHALMICS IBERICA S.L. | 1973-05-01 | 1 | 1 | 1 | 1973-05-01 | 2011-03-16 | 1 | 2011-10-17 | 695262, 653224 | View Edit Delete | |||||||||||
| 672095 | 22414 | COLIROFTA ANESTESICO 5 MG/ML + 0,5 MG/ML COLIRIO EN SOLUCION | COLIROFTA ANESTESICO 5 MG/ML + 0,5 MG/ML COLIRIO EN SOLUCION, 1 frasco de 10 ml | 0,5 mg/ml + 5 mg/ml | 56 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/22414/22414_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/22414/22414_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35498 | ALCON HEALTHCARE S.A. | 1954-12-01 | 1 | 1 | 1 | 1954-12-01 | 2011-03-16 | 1 | 2011-10-17 | 735159, 999804, 656486, 656837 | View Edit Delete | |||||||||||
| 672225 | 72544 | SATIVEX 2,7 MG/2,5 MG SOLUCION PARA PULVERIZACION BUCAL | SATIVEX 2,7 MG/2,5 MG SOLUCION PARA PULVERIZACION BUCAL , 3 envase de 10 ml | 2,7 mg/dosis + 2,5 mg/dosis | 68 | 30 | 26 | 3 envase de 10 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72544/72544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72544/72544_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 67204 | ALMIRALL S.A. | 2010-07-16 | 1 | 1 | 1 | 2010-07-16 | 2010-07-16 | 1 | 2011-03-10 | Lista II | View Edit Delete | |||||||||||
| 673016 | 62263 | NATECAL D 1.500 MG/400 UI COMPRIMIDOS MASTICABLES | NATECAL D 1.500 MG/400 UI COMPRIMIDOS MASTICABLES , 60 comprimidos | 1.500 mg (600 mg Ca)/400 UI | 72 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62263/62263_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62263/62263_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 1999-02-01 | 1 | 1 | 1 | 1999-02-01 | 2011-05-30 | 1 | 2011-07-11 | 656405 | View Edit Delete | |||||||||||
| 672129 | 63677 | EPINITRIL 10 mg/24 H PARCHES TRANSDERMICOS | EPINITRIL 10 mg/24 H PARCHES TRANSDERMICOS, 30 parches | 10 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63677/63677_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63677/63677_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2001-02-20 | 1 | 1 | 1 | 2001-02-20 | 2011-03-07 | 0 | 2011-04-12 | 705103 | View Edit Delete | |||||||||||
| 672130 | 63678 | EPINITRIL 15 mg/24 H PARCHES TRANSDERMICOS | EPINITRIL 15 mg/24 H PARCHES TRANSDERMICOS, 30 parches | 15 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63678/63678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63678/63678_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2001-02-20 | 1 | 1 | 1 | 2001-02-20 | 2011-03-07 | 0 | 2011-04-12 | 705681 | View Edit Delete | |||||||||||
| 672131 | 63676 | EPINITRIL 5mg / 24H PARCHES TRANSDERMICOS | EPINITRIL 5mg / 24H PARCHES TRANSDERMICOS, 30 parches | 5 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63676/63676_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63676/63676_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2001-02-20 | 1 | 1 | 1 | 2001-02-20 | 2011-03-07 | 0 | 2011-04-12 | 704668 | View Edit Delete | |||||||||||
| 672498 | 73003 | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL, 1 frasco de 120 ml | 3,54 mg/ml | 88 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73003/73003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73003/73003_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-11-15 | 1 | 1 | 1 | 2010-11-15 | 2010-11-15 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 672499 | 73003 | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL | CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORAL, 1 frasco de 200 ml | 3,54 mg/ml | 88 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73003/73003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73003/73003_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-11-15 | 1 | 1 | 1 | 2010-11-15 | 2010-11-15 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 677362 | 73563 | SALBUAIR 2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | SALBUAIR 2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR , 60 ampollas de 2,5 ml | 2,5 mg | 1 | 60 | 40 | 60 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73563/73563_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73563/73563_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677363 | 73562 | SALBUAIR 5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | SALBUAIR 5 mg SOLUCION PARA INHALACION POR NEBULIZADOR, 60 ampollas de 2,5 ml | 5 mg | 1 | 60 | 40 | 60 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73562/73562_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73562/73562_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677602 | 73561 | COMBIPRASAL 0.5 mg/2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | COMBIPRASAL 0.5 mg/2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR, 20 ampollas de 2,5 ml | 2,5 mg/0,5 mg | 1 | 20 | 40 | 20 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73561/73561_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73561/73561_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677494 | 73418 | VALSARTAN TARBIS 160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN TARBIS 160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73418/73418_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73418/73418_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-02-03 | 1 | 1 | 1 | 2019-12-18 | 2019-12-18 | 0 | 2020-02-20 | View Edit Delete | ||||||||||||
| 677496 | 73417 | VALSARTAN TARBIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN TARBIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73417/73417_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73417/73417_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-02-03 | 1 | 1 | 1 | 2019-12-18 | 2019-12-18 | 0 | 2020-02-20 | View Edit Delete | ||||||||||||
| 677537 | 73532 | RAMIPRIL TARBIS 5 mg COMPRIMIDOS EFG | RAMIPRIL TARBIS 5 mg COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73532/73532_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73532/73532_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-02-16 | 1 | 1 | 1 | 2011-02-16 | 2011-02-16 | 1 | 2012-09-06 | View Edit Delete | ||||||||||||
| 677538 | 73533 | RAMIPRIL TARBIS 10 mg COMPRIMIDOS EFG | RAMIPRIL TARBIS 10 mg COMPRIMIDOS EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73533/73533_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73533/73533_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-02-16 | 1 | 1 | 1 | 2011-02-16 | 2011-02-16 | 1 | 2012-09-06 | View Edit Delete |
Page 202 of 1036, showing 20 records out of 20709 total, starting on record 4021, ending on 4040